Semhar Abraham Mekonen, APRN, Cpnppc, MSN

Semhar Mekonen practices at Academic Alliance in Dermatology in Clearwater, Florida.

Semhar Mekonen's NPI, 1205357654, was assigned on July 6, 2017. Semhar Mekonen holds Florida license APRN9274983.

Semhar Mekonen's primary practice is Academic Alliance in Dermatology, at 3165 McMullen Booth Rd, Clearwater, FL 33761 in Pinellas County. The practice phone is (813) 882-9986.

Semhar Mekonen's primary practice is Academic Alliance in Dermatology in Clearwater, Florida. The medical group on file is Academic Alliance in Dermatology. Dmand AI also links Semhar Mekonen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Semhar Mekonen practices. Vendor and product names are available with a free account.

Nurse practitioner is Semhar Mekonen's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Semhar Mekonen is licensed in Florida.

Dmand AI lists benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes, psoriasis, rash and scalp rash among the conditions Semhar Mekonen treats.

CMS data shows 432 Medicare services from Semhar Mekonen across 8 procedure codes in 2024, for 245 Medicare patients. Medicare paid $20,734 for them. Every service was in an office.

CMS counts 245 Medicare patients who saw Semhar Mekonen in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Semhar Mekonen's median patient age at 58, with 60% women.

In 2024, Semhar Mekonen wrote 831 Medicare Part D claims for 322 patients. 95% of them were for generic drugs. CMS names the drug for 699 of them, across 13 drugs with 11 or more claims each, at $107,563 in total drug cost.

Semhar Mekonen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 97 general payments to Semhar Mekonen from 16 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $924.